Crossmark

Biocatalytic retrosynthesis approaches to<scp>d</scp>-(2,4,5-trifluorophenyl)alanine, key precursor of the antidiabetic sitagliptin

Crossref DOI link: https://doi.org/10.1039/C9GC01902B

Published Online: 2019

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Parmeggiani, Fabio https://orcid.org/0000-0001-5861-9269
Rué Casamajo, Arnau https://orcid.org/0000-0001-8932-8763
Colombo, Danilo

Ghezzi, Maria Chiara

Galman, James L. https://orcid.org/0000-0003-2076-2806
Chica, Roberto A. https://orcid.org/0000-0003-3789-9841
Brenna, Elisabetta https://orcid.org/0000-0002-1315-7248
Turner, Nicholas J. https://orcid.org/0000-0002-8708-0781
Funding

Funding for this research was provided by:

H2020 European Research Council (ERC-AdG 742987)

Ontario Ministry of Economic Development and Innovation (ER14-10-139)

Natural Sciences and Engineering Research Council of Canada (RGPIN-2016-04831)

Canada Foundation for Innovation (26503)
License Information

Accepted Manuscript valid from 2020-07-18
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Fabio Parmeggiani (ORCID)

: Fabio Parmeggiani (ResearcherID)

: Arnau Rué Casamajo (ORCID)

: James L. Galman (ORCID)

: Roberto A. Chica (ORCID)

: Elisabetta Brenna (ORCID)

: Elisabetta Brenna (ResearcherID)

: Nicholas J. Turner (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 6 June 2019; Accepted 18 July 2019; Accepted Manuscript published 18 July 2019; Advance Article published 25 July 2019; Version of Record published 12 August 2019